UC BRAID Center for Accelerated Innovation

加州大学加速创新中心建议创造新的机制，并 利用其在诊断、治疗和设备方面的不同优势，支持有希望的 为患者造福的早期发明。该中心是由加州大学五所医学院组成的联合体： 戴维斯、加州大学欧文分校、加州大学洛杉矶分校、加州大学圣地亚哥分校和加州大学旧金山分校。每个校园都有一个欣欣向荣的 临床资助的科研企业、国家级医学院、转化型研究所 和翻译科学奖(CTSA)。我们的五个校区加起来占NHLBI的近7% 拨款。 该中心利用加州传奇的生物医学和工程生态系统的活力和创造力 并整合了我们校园中许多成功的商业、工程和健康科学项目。 我们的计划将与知名的生物医药公司、风险投资公司、行业 组织和非营利组织专注于医疗创新。该中心由加州大学生物医学中心提供支持 研究加速、集成和开发(UC Braid)，这是五家UC生物医学公司的联合努力 旨在催化和加速整个UC的生物医学、临床和转化性研究的园区 系统。我们将共同努力：1)让加州大学的心脏、肺和血液疾病创新者参与 通过全面的教育、培训和指导计划培养企业家精神。2)征集选拔 具有高商业潜力的技术，符合NHLBI的使命并解决未满足的医疗问题 需要或重大的科学机会。3)按照以下要求孵化我们最有前途的技术 行业要求，以促进将其转换为商业产品，以改善患者护理和 增进健康。4)创建高性能、可持续的基础设施，作为 学术研究中心。 这些计划将创建一个集成、可持续的基础设施，以加快我们的 NHLBI资助的发现推向市场，以促进健康和改善患者护理。

The University of California Center for Accelerated Innovation proposes to create new mechanisms and to leverage its diverse strengths in diagnostics, therapeutics, and devices to support translation of promising early-stage inventions for patient benefit. The Center is a consortium of the five UC medical campuses: UC Davis, UC Irvine, UC Los Angeles, UC San Diego, and UC San Francisco. Each campus has a thriving research enterprise, nationally ranked medical school, and translational research institute funded by Clinical and Translational Science Awards (CTSA). Together, our five campuses account for nearly 7% of NHLBI's grant funding. The Center taps into the vigor and creativity of California's legendary biomedical and engineering ecosystem and integrates the many successful business, engineering and health sciences programs at our campuses. Our program will partner with well-established biomedical companies, venture capital firms, industry organizations and nonprofits focused on medical innovation. The Center is supported by UC Biomedical Research Acceleration, Integration, and Development (UC BRAID), a joint effort of the five UC biomedical campuses designed to catalyze and accelerate biomedical, clinical, and translational research across the UC system. Together we will: 1) Engage University of California heart, lung and blood disease innovators in entrepreneurism through a comprehensive education, training and mentorship program. 2) Solicit and select technologies with high commercial potential that align with NHLBI's mission and address unmet medical needs or significant scientific opportunity. 3) Incubate our most promising technologies in accordance with industry requirements to facilitate their translation to commercial products that improve patient care and enhance health. 4) Create a high-performing, sustainable infrastructure that will serve as a model to academic research centers. These programs will create an integrated, sustainable infrastructure to accelerate the translation of our NHLBI-funded discoveries to the marketplace in order to promote health and improve patient care.